BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3966755)

  • 1. Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors.
    Tsokos GC; Gorden P; Antonovych T; Wilson CB; Balow JE
    Ann Intern Med; 1985 Feb; 102(2):176-81. PubMed ID: 3966755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B4 infection.
    el-Reshaid K; al-Mofti S; Stepic NR
    Diabetes Res Clin Pract; 1994 Oct; 25(3):207-10. PubMed ID: 7851276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS; Johnson JL; Elliott-Mills D; Opas LM
    Lupus; 1997; 6(3):275-8. PubMed ID: 9104736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lupus, insulin-resistant diabetes and acanthosis nigricans (author's transl)].
    Wechsler B; Michel JP; Molle D; Wechsler J; Franceschini P; Liozon F; Godeau P
    Ann Dermatol Venereol; 1981; 108(1):23-30. PubMed ID: 7235501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus.
    Moller DE; Ratner RE; Borenstein DG; Taylor SI
    Am J Med; 1988 Feb; 84(2):334-8. PubMed ID: 3044073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of diffuse proliferative glomerulonephritis to membranous nephritis in a patient with systemic lupus erythematosus.
    Hall-Craggs M; Ramos E
    Nephron; 1981; 28(1):42-5. PubMed ID: 7266728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal insulin receptor type-B associated with lupus erythematosus].
    Saito N; Usami K; Miyazaki M; Nishimaki T; Yoshida H; Kasukawa R; Asano S; Kamiyama S; Wakasa H; Goto K
    Nihon Rinsho; 1983 Oct; 41(10):2412-20. PubMed ID: 6668704
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunopathology of early and clinically silent lupus nephropathy.
    Cavallo T; Cameron WR; Lapenas D
    Am J Pathol; 1977 Apr; 87(1):1-18. PubMed ID: 322502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
    Sinniah R; Feng PH
    Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of type I (insulin-dependent) diabetes mellitus, autoimmunity, antinuclear antibody, and membranoproliferative glomerulonephritis.
    Srikanta S; Malaviya AN; Rajagopalan P; Bhuyan UN; Ahuja MM
    Diabetes Care; 1983; 6(1):71-4. PubMed ID: 6220878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus nephritis and lupus band test.
    Adam BA; Wang F; Looi LM; Prathap K
    Postgrad Med J; 1981 Aug; 57(670):499-501. PubMed ID: 7029503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycaemia.
    Tardella L; Rossetti L; De Pirro R; Camagna A; Leonetti F; Tamburrano G; Merli M; Rossi Fanelli F; Lauro R
    J Clin Lab Immunol; 1983 Nov; 12(3):159-65. PubMed ID: 6663610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
    Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
    Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type B insulin resistance syndrome with systemic lupus erythematosus.
    Sato N; Ohsawa I; Takagi M; Gohda T; Horikoshi S; Shirato I; Yamaguchi Y; Tomino Y
    Clin Nephrol; 2010 Feb; 73(2):157-62. PubMed ID: 20129024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.
    Siegert CE; Daha MR; Tseng CM; Coremans IE; van Es LA; Breedveld FC
    Ann Rheum Dis; 1993 Dec; 52(12):851-6. PubMed ID: 8311534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment.
    Woolf A; Croker B; Osofsky SG; Kredich DW
    Pediatrics; 1979 Nov; 64(5):678-85. PubMed ID: 386241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual transformations of renal involvement in systemic lupus erythematosus.
    Yeung CK; Wong KL; Wong WS; Chan MK; Ng WL
    Aust N Z J Med; 1985 Feb; 15(1):69-71. PubMed ID: 3859270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.